BioCentury
ARTICLE | Company News

Sanofi, Verily deal

September 19, 2016 7:00 AM UTC

Sanofi and Verily launched Onduo (Cambridge, Mass.), a JV that plans to develop a diabetes management platform combining devices, software, medicine and professional care. Sanofi said each company contributed $248 million. Onduo initially will focus on Type II diabetes. It plans to involve clinicians, payers and the diabetes community in the product development process. ...